Skip to main content

This is a critical moment for patients with Opioid and Substance Use Disorders.

Of 1.1 million OUD patients prescribed treatment with buprenorphine, 1 million did not receive psychotherapy.8

Clinicians face significant barriers to providing therapy.

Social Stigma

13.5% of adults who feel they need treatment for substance use cite the possible negative opinion of their community as a reason for not receiving treatment.5

Access to Therapy

A study cites 64% (n=50) of physicians who don’t prescribe X Buprenorphine is an opioid medication used to treat opioid addiction. buprenorphine reported lack of mental health and psychosocial support for patients as a perceived obstacle to prescribing.6

Gaps in Care

Care transitions are critical moments for patients receiving treatment for substance use. Reduced touchpoints from intensive to outpatient care settings can lead to patient drop-out.7

Prescription digital therapeutics can help bridge gaps in care.

Learn More
Learn More
  • Provide consistent evidence-based therapy.

  • 24/7 access means patients can engage in therapy privately and on their own time.

  • Encourage patient engagement with the use of digital technology.

  • Can be personalized according to each patient’s needs.

Provide 24/7 access to therapy
with reSET-O and reSET.

How It Works

References: 1. Opioid Overdose Crisis. National Institute on Drug Abuse Website. https://www.drugabuse.gov/drugs-abuse/opioids/opioid-overdose-crisis#one. Updated January 2019. Accessed July 8, 2019. 2. CDC/NCHS, National Vital Statistics System, Mortality. CDC WONDER, Atlanta, GA: US Department of Health and Human Services, CDC; 2018. https://wonder.cdc.gov. Accessed July 8, 2019 3. Overdose Death Rates. National Institute on Drug Abuse Website. https://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates. Revised January 2019. Accessed March 20, 2019. 4. Principles of Drug Addiction Treatment: A Research-Based Guide (Third Edition). National Institute on Drug Abuse Website. https://www.drugabuse.gov/publications/principles-drug-addiction-treatment-research-based-guide-third-edition/preface. Updated January 2018. Accessed March 2019. 5. Bose J, Hedden SL, Lipari RN, Park-Lee E. Results from the 2017 national survey on drug use and health: detailed tables. Substance Abuse and Mental Health Services Administration Website. https://www.samhsa.gov/data/sites/default/files/cbhsq-reports/NSDUHFFR2017/NSDUHFFR2017.htm. Accessed March 20, 2019. 6. Hutchinson E, Catlin M, Andrillas CHA, Baldwin LM, Rosenblatt RA. Barriers to primary care physicians prescribing buprenorphine. Ann Fam Med. 2014;12(2):128-133 7. Forman RF, Nagy PD. Substance Abuse: Clinical Issues in Intensive Outpatient Treatment. Treatment Improvement Protocol TIP 47. Rockville, MD: U.S. Dept. of Health and Human Services. 2006. DHHS Publication No. (SMA) 06-4182. 8. Patient/HCP/Payor Insights a Compendium Based on SHS Data. reSET & reSET-O Symphony Data Analysis Compendium. Data on file. February 2019.